147 related articles for article (PubMed ID: 38425703)
1. Cognitive impairment and neuropsychiatric symptoms among individuals with history of symptomatic SARS-CoV-2 infection: a retrospective longitudinal study.
Sousa NMF; Maranhão ACPF; Braga LW
Dement Neuropsychol; 2024; 18():e20230053. PubMed ID: 38425703
[TBL] [Abstract][Full Text] [Related]
2. Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up.
Peskar M; Šimunič B; Šlosar L; Pišot S; Teraž K; Gasparini M; Pišot R; Marusic U
Front Psychol; 2023; 14():1141809. PubMed ID: 37303911
[TBL] [Abstract][Full Text] [Related]
3. Effects of an empowerment-based educative psycho-behavioral program on neuropsychiatric symptoms among persons with mild cognitive impairment: A mixed methods study.
Lin RSY; Yu DSF; Chau PH; Li PWC
Int J Nurs Stud; 2023 Jan; 137():104381. PubMed ID: 36402056
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection.
Goldstein FC; Hajjar I; Summers A; Truong AD; Lee FFE; Han JE; Walker TA
Brain Behav Immun Health; 2023 Dec; 34():100691. PubMed ID: 37842136
[TBL] [Abstract][Full Text] [Related]
6. Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach.
Ludwig B; Deckert M; Krajnc N; Keritam O; Macher S; Bsteh G; Zulehner G; Thurnher M; Berger T; Seidel S; Willinger U; Rommer P
Eur J Neurol; 2023 Sep; 30(9):2713-2725. PubMed ID: 37306533
[TBL] [Abstract][Full Text] [Related]
7. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
8. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort.
Del Brutto OH; Wu S; Mera RM; Costa AF; Recalde BY; Issa NP
Eur J Neurol; 2021 Oct; 28(10):3245-3253. PubMed ID: 33576150
[TBL] [Abstract][Full Text] [Related]
9. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
de Erausquin GA; Snyder H; Brugha TS; Seshadri S; Carrillo M; Sagar R; Huang Y; Newton C; Tartaglia C; Teunissen C; Håkanson K; Akinyemi R; Prasad K; D'Avossa G; Gonzalez-Aleman G; Hosseini A; Vavougios GD; Sachdev P; Bankart J; Mors NPO; Lipton R; Katz M; Fox PT; Katshu MZ; Iyengar MS; Weinstein G; Sohrabi HR; Jenkins R; Stein DJ; Hugon J; Mavreas V; Blangero J; Cruchaga C; Krishna M; Wadoo O; Becerra R; Zwir I; Longstreth WT; Kroenenberg G; Edison P; Mukaetova-Ladinska E; Staufenberg E; Figueredo-Aguiar M; Yécora A; Vaca F; Zamponi HP; Re VL; Majid A; Sundarakumar J; Gonzalez HM; Geerlings MI; Skoog I; Salmoiraghi A; Boneschi FM; Patel VN; Santos JM; Arroyo GR; Moreno AC; Felix P; Gallo C; Arai H; Yamada M; Iwatsubo T; Sharma M; Chakraborty N; Ferreccio C; Akena D; Brayne C; Maestre G; Blangero SW; Brusco LI; Siddarth P; Hughes TM; Zuñiga AR; Kambeitz J; Laza AR; Allen N; Panos S; Merrill D; Ibáñez A; Tsuang D; Valishvili N; Shrestha S; Wang S; Padma V; Anstey KJ; Ravindrdanath V; Blennow K; Mullins P; Łojek E; Pria A; Mosley TH; Gowland P; Girard TD; Bowtell R; Vahidy FS
Alzheimers Dement (N Y); 2022; 8(1):e12348. PubMed ID: 36185993
[TBL] [Abstract][Full Text] [Related]
10. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
11. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
Hartung TJ; Neumann C; Bahmer T; Chaplinskaya-Sobol I; Endres M; Geritz J; Haeusler KG; Heuschmann PU; Hildesheim H; Hinz A; Hopff S; Horn A; Krawczak M; Krist L; Kudelka J; Lieb W; Maetzler C; Mehnert-Theuerkauf A; Montellano FA; Morbach C; Schmidt S; Schreiber S; Steigerwald F; Störk S; Maetzler W; Finke C
EClinicalMedicine; 2022 Nov; 53():101651. PubMed ID: 36133318
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
14. Rapid improvement in severe long COVID following perispinal etanercept.
Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study.
Ferrando SJ; Dornbush R; Lynch S; Shahar S; Klepacz L; Karmen CL; Chen D; Lobo SA; Lerman D
J Acad Consult Liaison Psychiatry; 2022; 63(5):474-484. PubMed ID: 35085824
[TBL] [Abstract][Full Text] [Related]
16. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms.
Delgado-Alonso C; Díez-Cirarda M; Pagán J; Pérez-Izquierdo C; Oliver-Mas S; Fernández-Romero L; Martínez-Petit Á; Valles-Salgado M; Gil-Moreno MJ; Yus M; Matías-Guiu J; Ayala JL; Matias-Guiu JA
Eur J Neurol; 2023 Oct; ():. PubMed ID: 37797297
[TBL] [Abstract][Full Text] [Related]
17. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
[TBL] [Abstract][Full Text] [Related]
18. Cognitive consequences of COVID-19: results of a cohort study from South America.
Crivelli L; Calandri I; Corvalán N; Carello MA; Keller G; Martínez C; Arruabarrena M; Allegri R
Arq Neuropsiquiatr; 2022 Mar; 80(3):240-247. PubMed ID: 34816972
[TBL] [Abstract][Full Text] [Related]
19. Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study.
Diana L; Regazzoni R; Sozzi M; Piconi S; Borghesi L; Lazzaroni E; Basilico P; Aliprandi A; Bolognini N; Bonardi DR; Colombo D; Salmaggi A
J Neurol Sci; 2023 Jan; 444():120511. PubMed ID: 36473347
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
